Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation (Q46302700)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation |
scientific article |
Statements
1 reference
Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation (English)
1 reference
Ignarro LJ
1 reference
Byrns RE
1 reference
Buga GM
1 reference
Wood KS
1 reference
Chaudhuri G
1 reference
1 January 1988
1 reference
244
1 reference
1
1 reference
181-189
1 reference